Foghorn TherapeuticsÂ Inc (FHTX) Financials

$4.14

$-0.06 (-1.43%)

As on 18-Sep-2026 16:03EDT

Market cap

$246 Mln

Revenue (TTM)

$37 Mln

P/E Ratio

--

P/B Ratio

2005.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	36.74	30.91	22.60	34.16	19.23	1.32
Cost of Revenue	21.04	3.33	3.12	109.69	0.02	7.52
Gross Profit	15.70	27.58	22.60	34.16	19.21	1.32
Operating Expenses	84.17	109.68	125.29	142.06	136.37	102.05
Operating Profit (EBIT)	-68.48	-82.11	-102.68	-107.91	-117.14	-100.73
Other Income	--	--	--	--	8.26	1.32
Profit before Tax	-64.58	-74.28	-86.62	-94.20	-108.88	-101.32
Provision for Tax	--	--	--	4.23	-0.01	1.91
Profit after Tax (Net Income)	-64.58	-74.28	-86.62	-98.43	-108.87	-101.32
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-108.88	-101.32

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-81.04	-108.50	-45.53	-77.19	0.11	96.87
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	233.86	246.87	262.52	304.67	349.57	374.21
Current Liabilities	50.58	59.74	66.99	58.44	55.21	48.69
Total Liabilities	253.97	198.10	283.98	285.92	404.88	519.77

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	33.35	34.87	34.38	45.74	53.48	60.21
Current Assets	170.05	163.24	249.60	240.18	351.40	459.56
Total Assets	253.97	198.10	283.98	285.92	404.88	519.77
Total Debt*	43.10	41.27	37.13	45.07	51.51	58.33
Net Current Assets	119.47	103.50	182.61	181.75	296.19	410.87

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-86.10	-100.41	-118.11	193.61	-50.25
Cash Flow from Investing Activities	--	112.04	-29.90	144.45	-244.32	36.17
Cash from Financing Activities	--	1.02	105.43	1.78	1.76	22.42
Net Cash Inflow / Outflow	--	--	--	--	-48.95	8.34

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.98	-1.18	-1.38	-2.33	-2.60	-2.74
Cash EPS ($)	-0.97	-1.13	-1.33	-2.25	-2.52	-2.65
Adjusted Book Value ($)	-1.38	--	--	--	0.00	2.62
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.37	-1.60	-2.79	4.63	-1.36
Free Cash Flow per Share ($)	--	-1.37	-1.62	-2.82	4.60	-1.45

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	196.45	427.61	-1,009.39	-105.28	-52.86
ROE (%)	--	96.45	141.17	255.39	-224.52	-83.37
ROA (%)	-23.15	-30.82	-30.40	-28.50	-23.55	-26.13
EBIT Margin (%)	-175.78	-240.33	-443.70	-275.80	-609.20	-7,537.07
Net Margin (%)	-175.78	-240.33	-383.24	-288.17	-396.15	-3,839.33
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	51.98	0.37	-0.34	0.78	13.58	2.07
EBIT Growth (%)	14.35	25.93	-6.46	19.58	-17.83	-45.06
Net Profit Growth (%)	14.35	14.24	11.99	9.60	-7.46	-47.27
EPS Growth (%)	18.18	0.15	0.41	0.11	0.05	0.22
Book Value Growth (%)	5.74	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-4.58	-3.41	-2.77	-2.45	-8.35
Price / Book Value	2,005.35	-3.13	-6.49	-3.53	2,381.30	8.73
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.21	-3.14	-0.91	-0.92	0.24	-7.79
Close Price ($)	4.88	5.40	4.72	6.45	6.38	22.87
High Price ($)	6.95	6.79	10.25	9.97	24.34	25.10
Low Price ($)	3.27	2.94	2.70	2.84	5.32	8.01
Market Cap ($ Cr)	245.86	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	-0.38	-0.82	-0.58	459.88	0.60
Short term debt to equity ratio	-0.03	-0.01	-0.20	-0.11	53.30	0.07
Current Ratio	3.36	2.73	3.73	4.11	6.37	9.44
Quick Ratio	3.36	--	--	--	--	16.69
Interest Coverage	--	--	--	--	-10.13	-52.16

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	12.37	22,744.50
Asset Turnover	0.13	0.13	0.08	0.10	0.04	0.00
Receivable days	--	--	--	25.44	2,871.96	41,653.73
Inventory Days	--	--	--	--	-6,708,400.94	-17,164.22
Payable days	--	441.27	587.97	19.44	87,693.81	182.24
Cash Conversion Cycle	--	--	--	--	-6,793,222.80	24,307.27

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.